US MDMA (Medical Device Manufacturers Association) says GPOs' mark-ups are threat to competition
This article was originally published in Clinica
The US Medical Device Manufacturers Association (MDMA) has asked the office of inspector general (IG) to consider altering how it handles a "safe harbor" rule that is essential to keep group purchasing organisations from violating federal antitrust laws.
You may also be interested in...
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Alpha Source hired a new CEO from Mayline, while Mölnlycke’s CEO comes from CellaVision; Xvivo Perfusion finance chief changed job to become chief operating officer; Shire senior VP now COO at AVITA; and more.
Our updated graphic tracker of key developments from the leading vaccine candidates.